Squamous cell carcinoma (SCC) is an epithelial malignant tumor, and is found in many tissues. For example, SCC is thought to account for more than 90% of esophageal cancers, more than 80% of the cervical cancers, and more than 30% of lung cancers…
source : http://www.foxnews.com/health/2013/06/26/mexico-restricts-us-live-hog-imports-due-to-piglet-virus/
The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma (PEL), a type of cancer for which those drugs were not expected to be effective. "It’s a reversal of the paradigm," said Preet Chaudhary, chief of the Nohl Division of Hematology and Blood Diseases at the Keck School of Medicine of USC and principal investigator of the study. "Our results suggest that this new class of drug may be an effective treatment for a wider range of cancers than previously thought." PEL is caused by infection with Kaposi’s sarcoma-associated herpes virus, the most common cause of cancer among patients with AIDS. The prognosis for PEL is poor, with a median survival of three to six months. …
source : http://www.foxnews.com/health/2013/06/25/deadly-piglet-virus-spreads-to-nearly-200-us-farm-sites/
source : http://www.foxnews.com/health/2013/06/19/should-give-up-gluten/
source : http://www.foxnews.com/health/2013/06/19/hpv-vaccine-reducing-infection-rates-in-teen-girls-study-shows/
source : http://www.foxnews.com/health/2013/06/19/outbreak-deadly-piglet-virus-spreads-to-13-states/
source : http://www.foxnews.com/health/2013/06/19/american-medical-association-votes-to-recognize-obesity-as-disease/
A new study involving Sanford-Burnham Medical Research Institute’s Erkki Ruoslahti, M.D., Ph.D., contributing to work by Samir Mitragotri, Ph.D., at the University of California, Santa Barbara, found that the shape of nanoparticles can enhance drug targeting. The study, published in Proceedings of the National Academy of Sciences, found that rod-shaped nanoparticles — or nanorods — as opposed to spherical nanoparticles, appear to adhere more effectively to the surface of endothelial cells that line the inside of blood vessels. …
"The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy," said the study’s senior author, Valerie Gouon-Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sinai. "Until now, liver transplantation has been the most successful treatment for people with liver failure, but we have a drastic shortage of organs…